<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To further analyse the relationship between the new technology and clinical characteristers in <z:e sem="disease" ids="C0024790" disease_type="Disease or Syndrome" abbrv="PNH">paroxysmal nocturnal haemoglobinuria</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) patients, and summarize the data of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> during the past 15 years in China </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: 76 consecutive patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> diagnosed in Peking Union Medical Colleague Hospital from 1997 - 2011 retrospectively </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Most of the patients were diagnosed based on flow cytometric data </plain></SENT>
<SENT sid="3" pm="."><plain>There were 46 male and 30 female patients </plain></SENT>
<SENT sid="4" pm="."><plain>The median age at diagnosis was 40 (10 - 74) </plain></SENT>
<SENT sid="5" pm="."><plain>46 (60.5%) patients presented with classical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>, 16 (21.1%) <z:hpo ids='HP_0001876'>pancytopenias</z:hpo>, and 14 (18.4%) <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Anatomic locations of first <z:mp ids='MP_0005048'>thrombosis</z:mp> were intra abdominal in 7 patients, lower extremities in 3 patients, intracerebral in 2 patients, and pulmonary <z:mp ids='MP_0005048'>thrombosis</z:mp> in 2 patients </plain></SENT>
<SENT sid="7" pm="."><plain>The size of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clone at first determination (shown by CD55 and CD59 negative percentage) was (61.23 ± 27.47)% and (60.24 ± 25.59)% on neutrophils; (34.24 ± 25.50)% and (32.22 ± 23.12)% on erythrocytes, respectively </plain></SENT>
<SENT sid="8" pm="."><plain>The mean LDH level was (1199.2 ± 893.5) U/L </plain></SENT>
<SENT sid="9" pm="."><plain>In our cohort, 13(17.0%) patients suffered from renal deficiency, 12 (15.8%) patients <z:e sem="disease" ids="C0947622" disease_type="Disease or Syndrome" abbrv="">cholecystolithiasis</z:e>, 10 (13.2%) patients <z:mp ids='MP_0001914'>hemorrhage</z:mp> and 9 (11.8%) patients <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>In a median of 7-year (range 0.5 - 20 years) follow-up (68 patients), 2 (2.9%) patients developed into <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>/ <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, 1(1.5%) patient <z:e sem="disease" ids="C1140680" disease_type="Neoplastic Process" abbrv="">ovary cancer</z:e>, 11(14.5%) patients died </plain></SENT>
<SENT sid="11" pm="."><plain>Patients with <z:mp ids='MP_0005048'>thrombosis</z:mp> had higher percentage of CD59 negative neutrophils \[(73.45 ± 22.32)%\] compared with those without <z:mp ids='MP_0005048'>thrombosis</z:mp> \[(58.3 ± 20.2)%\] (P &lt; 0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: The cohort had higher percentage of classical <z:mp ids='MP_0010163'>hemolysis</z:mp>, <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:hpo ids='HP_0000082'>renal dysfunction</z:hpo> compared with previous reports in China </plain></SENT>
<SENT sid="13" pm="."><plain>Patients with thrombotic events had higher percentages of CD55 and CD59 negative neutrophils </plain></SENT>
</text></document>